Skip to main content
SpringerLink
Log in

Auricular and Periauricular Skin Cancers

  • Chapter
  • First Online:
Temporal Bone Cancer

  • 743 Accesses

Abstract

Cutaneous malignancy is the most common cancer worldwide and has been estimated to account for approximately one million new cases each year in the United States alone. Basal cell carcinoma makes up the overwhelming majority of these cases, accounting for 80%. The remainder is made up by squamous cell carcinoma, melanoma, and Merkel cell carcinoma. Approximately 80–90% of these malignancies appear on sun-exposed areas of the head and neck, and the auricle is estimated to be involved at an incidence of 5–10%.

Historically, cutaneous tumors of the auricle were thought to have similar malignant potential as other subsites. However, squamous cell carcinoma of the auricle has been shown to have a greater metastatic potential than other subsites, potentially related to its different histologic behavior with sun exposure compared to the rest of the body. Auricular melanoma was originally associated with a poorer prognosis; however, recent literature shows that survival outcomes of melanoma of the auricle are similar to those at other subsites of the body.

Treatment of advanced auricular lesions should involve a multidisciplinary tumor board approach. Due to its prominent location, the functionality and cosmetic appearance of the auricle require special attention during multidisciplinary management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. American Cancer Society. 2010, cited 2016 June. Available from http://cancer.org.

  2. Porceddu SV, Veness MJ, Guminski A. Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: current concepts, advances, and controversies. J Clin Oncol. 2015;33(29):3338–45.

    Article  CAS  PubMed  Google Scholar 

  3. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7.

    Article  PubMed  Google Scholar 

  4. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(3):975–83.

    Article  CAS  PubMed  Google Scholar 

  5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Basal cell and squamous cell skin cancers.

    Google Scholar 

  6. Clark RR, Soutar DS. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2008;61(10):1140–7.

    Article  CAS  PubMed  Google Scholar 

  7. Ahmad I, Das Gupta AR. Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna. J Laryngol Otol. 2001;115(2):85–6.

    Article  CAS  PubMed  Google Scholar 

  8. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous-cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol. 1992;26(6):976–90.

    Article  CAS  PubMed  Google Scholar 

  9. Mondin V, Rinaldo A, Shaha AR, et al. Malignant melanoma of the auricle. Acta Otolaryngol. 2005;125(11):1140–4.

    Article  PubMed  Google Scholar 

  10. Toia F, Garbo G, Tripoli M, et al. A systematic review on external ear melanoma. J Plast Reconstr Aesthet Surg. 2015;68(7):883–94.

    Article  PubMed  Google Scholar 

  11. Lachiewicz AM, Berwick M, Wiggins CL, et al. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol. 2008;144(4):515–21.

    Article  PubMed  Google Scholar 

  12. Ravin AG, Pickett N, Johnson JL, et al. Melanoma of the ear: treatment and survival probabilities based on 199 patients. Ann Plast Surg. 2006;57(1):70–6.

    Article  CAS  PubMed  Google Scholar 

  13. Dubas LE, Ingraffea A. Nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2013;21(1):43–53.

    Article  PubMed  Google Scholar 

  14. Rodgers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081–8.

    Article  Google Scholar 

  15. Jones TS, Jones EL, Gao D, et al. Management of external ear melanoma: the same of something different? Am J Surg. 2013;206(3):307–13.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lee D, Nash M, Har-El G. Regional spread of auricular and periauricular cutaneous malignancies. Laryngoscope. 1996;106(8):998–1001.

    Article  CAS  PubMed  Google Scholar 

  17. Gurudutt VV, Genden EM. Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer. 2011;2011:502723.

    Article  PubMed  PubMed Central  Google Scholar 

  18. National Cancer Institute. SEER Stat Fact Sheets: Melanoma of the Skin. Cited 2016 June. Available from http://seer.cancer.gov/statfacts/html/melan.html.

  19. Golger A, Young DS, Ghazarian D, et al. Epidemiological features and prognostic factors of cutaneous head and neck melanoma. Arch Otolaryngol Head Neck Surg. 2007;133(5):442–7.

    Article  PubMed  Google Scholar 

  20. Kolk A, Wolff KD, Kesting M, et al. Melanotic and non-melanotic malignancies of the face and external ear – a review of current treatment concepts and future options. Cancer Treat Rev. 2014;40(7):819–37.

    Article  PubMed  Google Scholar 

  21. Danial C, Lingala B, Balise R, et al. Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. Br J Dermatol. 2013;169(3):255–61.

    Article  Google Scholar 

  22. Mydlardz WK, Weber RS, Kupferman ME. Cutaneous malignancy of the head and neck. Surg Oncol Clin N Am. 2015;24(3):593–613.

    Article  Google Scholar 

  23. Saini AT, Miles BA. Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options. Onco Targets Ther. 2015;8:2157–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Chen MM, Roman SA, Sosa JA, et al. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma. JAMA Otolaryngol Head Neck Surg 2015;141(2):137–41.

    Article  Google Scholar 

  25. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gandhi SA, Kampp J. Skin cancer epidemiology, detection, and management. Med Clin N Am. 2015;99(6):1323–35.

    Article  PubMed  Google Scholar 

  27. Merlino G, Herlyn M, Fisher DE, et al. The state of melanoma: challenges and opportunities. Pigment Cell Melanoma Res. 2016;29(4):404–16.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shain AH, Bastian BC. From melanocytes to melanomas. Nat Rev Cancer. 2016;16(6):345–58.

    Article  CAS  PubMed  Google Scholar 

  29. IARC. Exposure to Artificial UV Radiation and Skin Cancer. Lyon, France:IARC Working Group on Risk of Skin Cancer and Exposure to Artificial Ultraviolet Light, International Agency for Research on Cancer, World Health Organization; 2005. [Online]. Available from http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk1/ArtificialUVRad&SkinCancer.pdf.

  30. Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Chockalingam R, Downing C, Tyring SK. Cutaneous squamous cell carcinomas in organ transplant recipients. J Clin Med. 2015;4(6):1229–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Walter A, Barysch MJ, Behnke S. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clin Cancer Res. 2010;16(14):3562–70.

    Article  CAS  PubMed  Google Scholar 

  33. Southwell KE, Chaplin JM, Eisenberg RL, et al. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck. 2006;28(3):244–8.

    Article  PubMed  Google Scholar 

  34. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management. Part I: Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65(2):253–61.

    Article  Google Scholar 

  35. Song SS, Goldenberg A, Ortiz A, et al. Nonmelanoma skin cancer with aggressive subclinical extension in immunosuppressed patients. JAMA Dermatol. 2016;152(6):683–90.

    Article  PubMed  Google Scholar 

  36. Ducroux E, Boillot O, Ocampo MA, et al. Skin cancers after liver transplantation: retrospective single-center study on 371 recipients. Transplantation. 2014;98(3):335–40.

    Article  PubMed  Google Scholar 

  37. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol. 2002;138(8):1043–51.

    Article  PubMed  Google Scholar 

  38. Jaju PD, Batra RS, Kelley LC. Familial skin cancer syndromes: increased risk of nonmelanotic skin cancers and extracutaneous tumors. J Am Acad Dermatol. 2016;74(3):437–51.

    Article  PubMed  Google Scholar 

  39. Ransohoff KJ, Jaju PD, Tang JY, et al. Familial skin cancer syndromes: increased melanoma risk. J Am Acad Dermatol. 2016;74(3):423–34.

    Article  PubMed  Google Scholar 

  40. Sajic D, Archibald J, Murray C. Surface anatomy of the ear. J Cutan Med Surg. 2014;18(2):137–40.

    Article  PubMed  Google Scholar 

  41. Osborne RF, Shaw T, Zandifar H, et al. Elective parotidectomy in the management of advanced auricular malignancies. Laryngoscope. 2008;118(12):2139–45.

    Article  PubMed  Google Scholar 

  42. Sand M, Sand D, Brors D, et al. Cutaneous lesions of the external ear. Head Face Med. 2008;4:2.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Thom JJ, Moore EJ, Price DL, et al. The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg. 2014;140(6):548–54.

    Article  PubMed  Google Scholar 

  44. Brantsh KD, Meisner C, Schonfish B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–20.

    Article  Google Scholar 

  45. Butler TD, Matin RN, Affleck AG, et al. Trends in dermoscopy use in the UK: results from surveys in 2003 and 2012. Dermatol Pract Concept. 2015;5(2):29–38.

    PubMed  PubMed Central  Google Scholar 

  46. Netterville JL, Sinard RJ, Bryant GL, et al. Delayed regional metastasis from midfacial squamous carcinomas. Head Neck. 1998;20(4):328–33.

    Article  CAS  PubMed  Google Scholar 

  47. Mendenhall WM, Amdur RJ, Williams LS, et al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck. 2002;24(1):78–83.

    Article  PubMed  Google Scholar 

  48. Warren TA, Nagle CM, Bowman J, et al. The natural history and treatment outcomes of perineural spread of malignancy within the head and neck. J Neurol Surg B Skull Base. 2016;77(2):107–12.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Pan WR, le Roux CM, Levy SM, et al. Lymphatic drainage of the external ear. Head Neck. 2011;33(1):60–4.

    Article  PubMed  Google Scholar 

  50. Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989–2007.

    Article  PubMed  Google Scholar 

  51. Zager JS, Hochwald SN, Marzban SS, et al. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg. 2011;212(4):454–60.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Scolyer RA, Judge MJ, Evans A, et al. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR). Am J Surg Pathol. 2013;37(12):1797–814.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Eisenmenger LB, Wiggins RH. Imaging of head and neck lymph nodes. Radiol Clin N Am. 2015;53(1):115–32.

    Article  PubMed  Google Scholar 

  54. Duncan JR, Carr D, Kaffenberger BH. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer. J Am Acad Dermatol. 2016;75(1):186–96.

    Article  PubMed  Google Scholar 

  55. Kumar R, Alavi A. Clinical applications of fluorodeoxyglucose – positron emission tomography in the management of malignant melanoma. Curr Opin Oncol. 2005;17(2):154–9.

    Article  PubMed  Google Scholar 

  56. Siva S, Byrne K, Seel M, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience. J Nucl Med. 2013;54(8):1223–9.

    Article  CAS  PubMed  Google Scholar 

  57. Byrne K, Siva S, Chait L, et al. 15-year experience of 18F-FDG PET imaging in response assessment and restaging after definitive treatment of Merkel cell carcinoma. J Nucl Med. 2015;56(9):1328–33.

    Article  CAS  PubMed  Google Scholar 

  58. Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol. 2011;64(6):1051–9.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Chu VH, Tetzladd MT, Torres-Cabala CA, et al. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int. 2013;2013:898719.

    PubMed  PubMed Central  Google Scholar 

  60. Alex JC. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope. 2004;114(1):2–19.

    Article  PubMed  Google Scholar 

  61. Caldarella A, Fancelli L, Manneschi G, et al. How staging of thin melanoma is changes after introduction of TMN 7th edition: a population-based analysis. J Cancer Res Clin Oncol. 2016;142(1):73–6.

    Article  CAS  PubMed  Google Scholar 

  62. Smithers BM, Hughes MC, Beesley VL, et al. Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk spread, in Queensland, Australia. J Surg Oncol. 2015;112(4):359–65.

    Article  PubMed  Google Scholar 

  63. Lansbury L, Bath-Hextall F, Perkins W, et al. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347:f6153.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Chren MM, Linos E, Torres JS, et al. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2013;133(5):1188–96.

    Article  CAS  PubMed  Google Scholar 

  65. McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg. 2004;23(3):174–83.

    Article  PubMed  Google Scholar 

  66. Erickson C, Miller SJ. Treatment options in melanoma in situ: topical and radiation therapy, excision, and Mohs surgery. Int J Dermatol. 2010;49(5):482–91.

    Article  PubMed  Google Scholar 

  67. Ermertcan AT, Hellings PW, Cingi X. Nonmelanoma skin cancer of the head and neck, nonsurgical treatment. Facial Plast Surg Clin North Am. 2012;20(4):445–54.

    Article  PubMed  Google Scholar 

  68. Niparko JK, Swanson NA, Baker SR, et al. Local control of auricular, periauricular and external canal cutaneous malignancies with Mohs surgery. Laryngoscope. 1990;100(10 Pt 1):1047–51.

    Article  CAS  PubMed  Google Scholar 

  69. Gupta A, Veness M, De’Ambrosis B, et al. Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion. Australas J Dermatol. 2016;57(1):3–13.

    Article  PubMed  Google Scholar 

  70. Baddour HM, Magliocca KR, Chen AY. The importance of margins in head and neck cancer. J Surg Oncol. 2016;113(3):248–55.

    Article  PubMed  Google Scholar 

  71. Craig ES, Nagarajan P, Lee ES, et al. The perichondrium in auricular melanomas: implications for surgical management. Otolaryngol Head Neck Surg. 2013;148(3):431–5.

    Article  PubMed  Google Scholar 

  72. McCarty MA, Lentsch EJ, Cerrati EW, et al. Melanoma of the ear: results of a cartilage-sparing approach to resection. Eur Arch Otorhinolaryngol. 2013;270(11):2963–7.

    Article  PubMed  Google Scholar 

  73. Jahn V, Breuninger H, Garbe C, et al. Melanoma of the ear: prognostic factors and surgical strategies. Br J Dermatol. 2006;154(2):310–8.

    Article  CAS  PubMed  Google Scholar 

  74. Yenidunya MO. Surgical treatment of auricular malignancies when the anterior or posterior skin is intact. J Craniofac Surg. 2013;24(2):350–3.

    Article  PubMed  Google Scholar 

  75. Mazzoni A, Zanoletti E, Marioni G, et al. En bloc temporal bone resections in squamous cell carcinoma of the ear. Technique, principles, and limits. Acta Otolaryngol. 2016;135(6):425–32.

    Article  Google Scholar 

  76. Kahn MK, Kahn N, Almasan A, et al. Future of radiation therapy for malignant melanoma an era of newer, more effective biological agents. Onco Tragets Ther. 2011;4:137–48.

    Article  CAS  Google Scholar 

  77. Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119(10):1994–9.

    Article  PubMed  Google Scholar 

  78. Clark RR, Soutar DS, Hunter KD. A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology. 2010;57(1):138–46.

    Article  PubMed  Google Scholar 

  79. Kadakia S, Ducic Y, Marra D, et al. The role of elective superficial parotidectomy in the treatment of temporal region squamous cell carcinoma. Oral Maxillofac Surg. 2016;20(2):143–7.

    Article  PubMed  Google Scholar 

  80. Michl C, Starz H, Bachter D, et al. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol. 2003;149(4):763–9.

    Article  CAS  PubMed  Google Scholar 

  81. Ahmed MM, Moore BA, Schmalbach CE. Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review. Otolaryngol Head Neck Surg. 2014;150(2):180–7.

    Article  PubMed  Google Scholar 

  82. Durham AB, Lowe L, Malloy KM, et al. Sentinel lymph node biopsy for cutaneous squamous cell carcinoma on the head and neck. JAMA Otolaryngol Head Neck Surg. 2016;142:1171–6. https://doi.org/10.1001/jamaoto.2016.1927.

    Article  PubMed  Google Scholar 

  83. Shpitzer T, Gutman H, Barnea Y, et al. Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the ear. Melanoma Res. 2007;17(6):365–9.

    Article  PubMed  Google Scholar 

  84. Valsecchi ME, Silbermins D, de Rosa N, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol. 2011;29(11):1479–87.

    Article  PubMed  Google Scholar 

  85. Patel SG, Coit DC, Shaha AR, et al. Sentinel lymph nose biopsy for cutaneous head and neck melanomas. Arch Otolaryngol Head Neck Surg. 2002;128(3):285–91.

    Article  PubMed  Google Scholar 

  86. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224(3):255–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Kesmodel SB, Karakousis GC. Botbyl, et al. Mitotic rate as a predictor of sentinel lymph node biopsy in thin melanomas. Ann Surg Oncol. 2005;12(6):449–58.

    Article  PubMed  Google Scholar 

  88. Phan GQ, Messina JL, Sondak VK, et al. Sentinel Lymph node biopsy for melanoma: indications and rationale. Cancer Control. 2009;16(3):234–9.

    Article  PubMed  Google Scholar 

  89. Morton DL. Overview and update of the phase III multicenter selective lymphadenectomy trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis. 2012;29(7):699–706.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Main BG, Coyle MJ, Godden A, et al. The metastatic potential of head and neck cutaneous malignant melanoma: is sentinel node biopsy useful? Br J Oral Maxillofac Surg. 2014;52(4):340–3.

    Article  CAS  PubMed  Google Scholar 

  92. Khurana VG, Mentis DH, O’Brien CJ, et al. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg. 1995;170(5):446–50.

    Article  CAS  PubMed  Google Scholar 

  93. Turner SJ, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. J Laryngol Otol. 2010;124(1):26–31.

    Article  CAS  PubMed  Google Scholar 

  94. Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;155(5):870–5.

    Article  Google Scholar 

  95. O’Hara J, Ferlito A, Takes RP. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland – a review of current recommendations. Head Neck. 2011;33(12):1789–95.

    Article  PubMed  Google Scholar 

  96. Medina JE. Posterolateral neck dissection. Oper Tech Otolaryngol. 2004;15:176–9.

    Article  Google Scholar 

  97. Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13(6):589–97.

    Article  PubMed  Google Scholar 

  98. Mathen P, Debenham BJ, Voroney JP, et al. Clinical outcomes in stage III cutaneous melanoma treated with adjuvant radiation therapy. Int J Radiat Biol Phys. 2016;96(2S):E714.

    Article  Google Scholar 

  99. Soura E, Chasapi V, Strarigos AJ. Pharmacologic treatment options for advanced epithelial skin cancer. Expert Opin Pharmacother. 2015;16(10):1479–93.

    Article  CAS  PubMed  Google Scholar 

  100. Rudnick EW, Thareja S, Cherpelis B. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies. Int J Dermatol. 2016;55(3):249–58.

    Article  CAS  PubMed  Google Scholar 

  101. Sekulic A, Migden MR, Lewis K, et al. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol. 2015;72(6):1021–6.

    Article  PubMed  Google Scholar 

  102. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78.

    Article  CAS  PubMed  Google Scholar 

  103. Pectasides D, Pectasides M, Psyrri A, et al. Cisplatin-based chemotherapy for Merkel cell carcinoma of the skin. Cancer Investig. 2006;24(8):780–5.

    Article  CAS  Google Scholar 

  104. Davey RJ, van der Westhuizen A, Bowden NA. Metastatic melanoma treatment: combining old and new therapies. Crit Rev Oncol Hematol. 2016;98:242–53.

    Article  PubMed  Google Scholar 

  105. Sharma A, Shah SR, Illum H, et al. Vemurafenib: targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies. Drugs. 2012;72(17):2207–22.

    Article  CAS  PubMed  Google Scholar 

  106. Hiniker SM, Reddy SA, Maecker HT, et al. A prospective clinical trial combining radiation therapy with systemic immunotherapy in metastatic melanoma. Int J Radiat Oncol Biol Phys. 2016;96(3):578–88.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology — Head and Neck Surgery, Ochsner Health System, New Orleans, LA, USA

    Blair Barton M.D. & Brian Moore M.D.

Authors
  1. Blair Barton M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Moore M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Head and Neck Surgery, Otology-Neurotology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Paul W. Gidley

  2. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Franco DeMonte

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Barton, B., Moore, B. (2018). Auricular and Periauricular Skin Cancers. In: Gidley, P., DeMonte, F. (eds) Temporal Bone Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74539-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74539-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74538-1

  • Online ISBN: 978-3-319-74539-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation